Page last updated: 2024-08-16

resveratrol and Diabetes Mellitus, Type 2

resveratrol has been researched along with Diabetes Mellitus, Type 2 in 141 studies

Research

Studies (141)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	13 (9.22)	29.6817
2010's	83 (58.87)	24.3611
2020's	45 (31.91)	2.80

Authors

Authors	Studies
Bemis, JE; Boss, O; Carney, DP; Choy, W; Disch, JS; Elliott, PJ; Gagne, DJ; Galonek, H; Iffland, A; Israelian, K; Jin, L; Jirousek, MR; Lambert, PD; Lavu, S; Lynch, AV; Medvedik, O; Milne, JC; Ng, PY; Nunes, JJ; Olefsky, JM; Perni, RB; Schenk, S; Sinclair, DA; Smith, JJ; Vu, CB; Westphal, CH; Xie, R; Yang, H	1
Bemis, JE; Carney, DP; Disch, JS; Gagne, DJ; Jirousek, MR; Lambert, PD; Lavu, S; Lynch, AV; Milne, JC; Ng, PY; Nunes, JJ; Olefsky, JM; Perni, RB; Schenk, S; Smith, JJ; Vu, CB	1
Katselou, MG; Kourounakis, AP; Matralis, AN	1
Guo, CL; Guo, SJ; Jiang, B; Li, N; Li, XQ; Shi, DY; Wang, LJ	1
Calazans, MO; De Oliveira, ACP; Ribeiro, R; Santos, AC; Vieira, LB	1
Abdelhaleem, IA; Aboalfetoh, AY; Adayel, HM; Asla, MM; Brakat, AM; Rizk, MA	1
Ariyanto, EF; Berbudi, A; Danil, AS; Rohmawaty, E; Sujatmiko, B	1
Khan, DA; Mahjabeen, W; Mirza, SA	1
Rabbani, N; Thornalley, PJ	1
Chi, Y; Liang, Y; Liu, S; Wang, H; Wang, Y; Wu, X; Zhu, B	1
Grużewska, K; Gul-Hinc, S; Jankowska-Kulawy, A; Michno, A; Ronowska, A; Zyśk, M	1
Abdollahi, S; Ali Sangouni, A; Mozaffari-Khosravi, H	1
Bodakhe, SH; Singh, A	1
El-Sayed, NS; Elatrebi, S; Ibrahim, HF; Omar, EM; Said, R	1
Akdemir, AS; Anapali, M; Aydemir, D; Kaya-Dagistanli, F; Ozturk, M; Tanriverdi, G; Ulusu, NN; Ulutin, T; Uysal, O	1
Barber, TM; Kabisch, S; Pfeiffer, AFH; Randeva, HS; Weickert, MO	1
Ma, N; Zhang, Y	1
García-Martínez, BI; Mendoza-Núñez, VM; Pedraza-Chaverri, J; Ruiz-Ramos, M; Santiago-Osorio, E	1
Fang, WJ; Li, XM; Xiong, Y; Zhou, XK	1
A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X	1
Deng, L; Deng, X; Sun, Y; Xu, M; Yang, M	1
Akbarizadeh, AR; Fatehi, R; Firouzabadi, N; Rashedinia, M; Zamani, M	1
Desousa, J; Drees, BM; Morrison, DC; Qureshi, AA; Qureshi, N; Siddiqui, AZ	1
Beaumont, P; Courtois, A; Eseberri, I; Gómez-Zorita, S; Krisa, S; Milton-Laskibar, I; Portillo, MP	1
Kmetič, I; Kovač, V; Miletić, M; Murati, T; Petković, T; Pleadin, J; Šimić, B; Štrac, DŠ	1
Grabowska, AD; Mikulska, A; Sepúlveda, N; Szukiewicz, D; Wątroba, M; Witkowska, J	1
Bednarzak, M; Grabowska, AD; Komorowska, J; Szukiewicz, D; Wątroba, M	1
Abdollahi, S; Fallahzadeh, H; Mozaffari-Khosravi, H; Rahmanian, M; Salehi-Abargouei, A; Sheikhha, MH; Tabatabaie, M; Toupchian, O	1
Deniziak, M; Hertig, I; Jaroszewska, M; Szkudelska, K; Szkudelski, T; Tyczewska, M; Wojciechowicz, T	1
Chen, YB; Du, L; Gu, XK; Hao, M; Jiang, YF; Li, CC; Li, XZ; Li, Y; Lu, Q; Wang, B; Wang, J; Wang, L; Yang, H; Yin, XX	1
Nanjappan, S; Paul, D; Sapkal, R; Surendran, S	1
Fu, J; Wang, X; Xu, G; Zhao, X	1
Abou-Setta, AM; Al-Yousif, NSH; Dolinsky, VW; Jeyaraman, MM; Rabbani, R; Singh Mann, A; Zarychanski, R	1
Alajez, NM; Aldahmash, A; Alfayez, M; Ali, D; AlMana, Y; AlObaidan, R; AlOtaibi, N; AlShehri, M; Chen, L; Hamam, R; Kassem, M; Kowal, JM; Manikandan, M; Okla, M	1
Hertig, I; Okulicz, M; Szkudelska, K; Szkudelski, T	1
Bi, R; Hua, Y; Li, Y; Li, Z	1
Abdollahi, S; Clark, CCT; Fallahzadeh, H; Karimi-Nazari, E; Mozaffari-Khosravi, H; Rahmanian, M; Salehi-Abargouei, A; Tabatabaie, M	1
Fathi, M; Hosseini, H; Khodabandehloo, H; Koushki, M; Majidi, Z; Meshkani, R; Panahi, G; Teimouri, M	1
Bagul, PK; Banerjee, SK; Rai, RC	1
Hou, G; Huang, W; Ma, H; Shu, L; Song, G; Zhao, H	1
Dludla, PV; Louw, J; Mazibuko-Mbeje, SE; Mokgalaboni, K; Mxinwa, V; Nkambule, BB; Nyambuya, TM; Orlando, P; Silvestri, S; Tiano, L	1
Okulicz, M; Szkudelska, K; Szkudelski, T	1
Cao, Z; Guo, X; Ma, Y; Shao, Y; Sun, X; Yuan, G; Zhang, J	1
de Ligt, M; Hesselink, MKC; Hoeks, J; Moonen-Kornips, E; Schaart, G; Schrauwen, P; Timmers, S; van Polanen, N; Zacharewicz, E	1
Delpino, FM; Figueiredo, LM	1
Acton, JP; Bailey, SJ; Clifford, T; Cocksedge, SP; Davies, KAB	1
Al-Ani, B; Al-Ghamdi, S; Aldossari, KK; El-Bidawy, MH; Haidara, MA; Omar Hussain, AB	1
Abdollahi, S; Clark, CCT; Fallahzadeh, H; Heshmati, J; Mozaffari-Khosravi, H; Salehi-Abargouei, A; Sheikhha, MH; Toupchian, O	1
Deniziak, M; Noskowiak, W; Sassek, M; Szkudelska, K; Szkudelski, I; Szkudelski, T	1
Al-Bader, MD; Al-Qaryyan, M; Kilarkaje, N	1
Jayedi, A; Shab-Bidar, S; Zeraattalab-Motlagh, S	1
Chen, TY; Cooper, B; Ferruzzi, MG; Ho, L; Janle, EM; Pasinetti, GM; Simon, JE; Talcott, ST; Todd, G; Wang, J; Wu, QL	1
Imamura, H; Nagayama, D; Saiki, A; Shirai, K; Tatsuno, I; Yamaguchi, T	1
Abbasi Oshaghi, E; Adeli, K; Goodarzi, MT; Higgins, V	1
González-Ortiz, M; Martínez-Abundis, E; Méndez-Del Villar, M; Pérez-Rubio, KG	1
de Ligt, M; Schrauwen, P; Timmers, S	1
Brianso-Llort, L; Hammond, GL; Saez-Lopez, C; Selva, DM; Simó, R; Torres-Torronteras, J	1
Bo, S; Brizzi, MF; Cassader, M; Gambino, R; Lombardo, G; Ponzo, V; Rosato, R; Togliatto, G	1
Khodabandehloo, H; Meshkani, R; Nasli Esfahani, E; Seyyedebrahimi, S	1
Akash, MSH; Munawar, SM; Rehman, K; Saeed, K	1
Bruls, YMH; de Ligt, M; Habets, MF; Hansen, J; Havekes, B; Moonen-Kornips, E; Nascimento, EBM; Schaart, G; Schrauwen, P; Schrauwen-Hinderling, VB; van Marken Lichtenbelt, W	1
Char, HP; Jonnalagadda, VG	1
Esfahani, EN; Khodabandehloo, H; Meshkani, R; Seyyedebrahimi, S	1
Esfahani, EN; Khodabandehloo, H; Meshkani, R; Razi, F; Seyyedebrahimi, S	1
Howe, PRC; Wong, RHX	1
Bo, S; Cassader, M; Ciccone, G; Cioffi, I; Evangelista, A; Gambino, R; Goitre, I; Ponzo, V; Procopio, M	1
Chen, B; Jiao, A; Lin, J; Lv, W; Wang, B; Zhang, J	1
Chen, KH; Hsu, SC; Huang, JP; Hung, LM; Kuo, CY; Li, DE	1
Akbari, M; Asemi, Z; Dabbaghmanesh, MH; Dadgostar, E; Kolahdooz, F; Lankarani, KB; Momen-Heravi, M; Shamshirian, A; Tabrizi, R; Tamtaji, OR	1
Lamuela-Raventós, RM; Laveriano-Santos, EP; Marhuenda-Muñoz, M; Ramírez-Garza, SL; Storniolo, CE; Tresserra-Rimbau, A; Vallverdú-Queralt, A	1
Alves-Wagner, AB; Correa-Giannella, ML; Esteves, JV; Giannella-Neto, D; Machado, UF; Okamoto, MM; Yonamine, CY	1
Ma, H; Shu, L; Song, A; Song, G; Zhang, Y; Zhao, H	1
Bernard, M; Desrois, M; Fourny, N; Lan, C; Sérée, E	1
Kaufman, RJ; Li, H; Monks, TJ; O'Meara, M; Seyoum, B; Wang, JM; Yi, Z; Zhang, K; Zhang, X	1
Bo, S; Brizzi, MF; Cassader, M; Fanni, G; Gambino, R; Goitre, I; Ponzo, V; Togliatto, G	1
Alizadeh, Z; Bahmanzadeh, M; Fathi, N; Goodarzi, MT; Rezaei Farimani, A	1
Abdollahi, S; Fallahzadeh, H; Karimi-Nazari, E; Mozaffari-Khosravi, H; Rahmanian, M; Salehi-Abargouei, A; Sheikhha, MH; Tabatabaie, M; Toupchian, O	1
Dávalos, A; Espín, JC; García-Almagro, FJ; García-Conesa, MT; Gil-Zamorano, J; Gonzálvez, M; Larrosa, M; Ruiz Ros, JA; Tomás-Barberán, FA; Tomé-Carneiro, J; Yáñez-Gascón, MJ	1
Alidori, A; Borroni, F; Faloia, E; Giulietti, A; Mazzanti, L; Nanetti, L; Raffaelli, F; Sforza, G; Vignini, A	1
Fujiwara, Y; Fukuhara, K; Hasebe, M; Ishii, A; Ito-Nagahata, T; Iwabuchi, M; Kurihara, C; Matsuoka, A; Sawada, R; Sonoda, M; Yamashita, K	1
Hesselink, MK; Schrauwen, P; Timmers, S	1
Carlson, OD; de Cabo, R; Doyle, ME; Egan, JM; Farhang, K; Fiori, JL; Gadkaree, SK; González-Mariscal, I; Kim, W; Krzysik-Walker, SM; Mattison, JA; Moaddel, R; Pearson, KJ; Sanghvi, M; Shin, YK	1
Chan, YH; Goh, KP; Koh, AF; Lau, DP; Lee, HY; Supaat, W	1
Li, J; Li, Y; Liu, M; Wei, M; Zhu, W	1
Beaudoin, MS; Herbst, EA; Holloway, GP; Neufer, PD; Perry, CG; Ritchie, IR; Smith, BK; Smith, JC; Wright, DC	1
Schrauwen, P; Timmers, S	1
Cao, Y; Chang, S; Dong, J; Li, J; Long, R; Zheng, X; Zhou, Y; Zhu, S	1
Dash, S; Lewis, GF; Morgantini, C; Xiao, C	1
Koh, KK; Lim, S; Quon, MJ	1
Liu, K; Mi, MT; Wang, B; Zhou, R	1
Hausenblas, HA; Schoulda, JA; Smoliga, JM	1
Ahmadieh, H; Arbabi-Aval, E; Ghadiri Soufi, F; Rezaei Kanavi, M	1
Bitterman, JL; Chung, JH	1
Koter-Michalak, M; Maćczak, A; Pytel, E; Sicińska, P	1
Álvarez, C; Cuadrado, A; Fernández-Millán, E; González-Rodríguez, Á; Mas-Gutierrez, JA; Pardo, V; Rada, P; Ros, M; Santamaría, B; Serrano, M; Valverde, ÁM	1
Mashghoolozekr, E; Mozafari, M; Nekooeian, AA; Panjeshahin, MR	1
Baggen, J; Chen, WJ; Diamant, M; Favre, J; Fontijn, R; Garcia-Vallejo, JJ; Horrevoets, AJ; Koolwijk, P; Leyen, TA; Musters, R; Serné, E; van der Pouw Kraan, T; van Genugten, RE; van Golen, LW; Yildirim, C	1
Goodarzi, MT; Karimi, J; Khazaei, M; Khodadadi, I; Moridi, H; Saidijam, M; Sheikh, N	1
Bound, MJ; Checklin, HL; Horowitz, M; Jones, KL; Rayner, CK; Standfield, S; Thazhath, SS; Wu, T	1
Hida, M; Kobayashi, T; Matsumoto, T; Taguchi, K	1
Brender, JR; Fierke, CA; Pithadia, A; Ramamoorthy, A	1
Dain, A; Das, UN; Diaz-Gerevini, GT; Eynard, AR; Repossi, G; Tarres, MC	1
Chen, Z; Duan, Z; Fu, R; Gao, J; Han, J; Jia, L; Lu, J; Lv, Z; Ma, L; Tian, L; Wang, L	1
Howe, PR; Nealon, RS; Scholey, A; Wong, RH	1
Gao, C; Liu, Y; Sun, L; Tao, L; Wang, HC; Yang, Q	1
Howe, PR; Raederstorff, D; Wong, RH	1
Bo, S; Cassader, M; Ciccone, G; Evangelista, A; Gambino, R; Goitre, I; Pagano, GF; Ponzo, V; Procopio, M; Saba, F	1
Bagul, PK; Banerjee, SK; Chakravarty, S; Jhelum, P; Kaur, G; Kumar, A; Kumar, KP; Maitra, S; Reddy, BR	1
Asadi, S; Goodarzi, MT; Khyripour, N; Mahmoodi, M; Moradi, MN	1
de Ligt, M; Hansen, J; Hesselink, MK; Kunz, I; Moonen-Kornips, E; Phielix, E; Schaart, G; Schrauwen, P; Schrauwen-Hinderling, VB; Timmers, S; van de Weijer, T	1
Bo, S; Cassader, M; Ciccone, G; Evangelista, A; Gambino, R; Goitre, I; Ponzo, V; Procopio, M; Saba, F	1
León, D; Salas, M; Uribe, E; Zambrano, A	1
Lam, KS; Liu, L; Wang, Y; Xu, A	1
Knutson, MD; Leeuwenburgh, C	1
Gohlke, A; Mishra, R; Radovan, D; Sellin, D; Winter, R	1
Opitz, N; Radovan, D; Winter, R	1
Ballabh, P; Csiszar, A; de Cabo, R; Labinskyy, N; Losonczy, G; Pacher, P; Pearson, K; Pinto, JT; Ungvari, Z; Zhang, C; Zhang, H	1
Chaudhary, N; Pfluger, PT	1
Ungvari, Z; Zhang, C; Zhang, H; Zhang, J	1
Coppari, R; Elmquist, JK; Fujikawa, T; Gautron, L; Ramadori, G; Vianna, CR	1
Ahn, K; Bleasdale, JE; Chrunyk, B; Cunningham, D; Flynn, D; Garofalo, RS; Griffith, D; Griffor, M; Loulakis, P; Pabst, B; Pacholec, M; Qiu, X; Stockman, B; Thanabal, V; Varghese, A; Ward, J; Withka, J	1
Arumugam, S; Davis, JA; Misra, CS; Ray, A; Roy, S; Shah, V; Sharma, S; Shirumalla, RK	1
Dellsperger, KC; Ma, L; Morgan, B; Potter, BJ; Ungvari, Z; Zhang, C; Zhang, H	1
Chan-Park, MB; Jiang, P; Li, H; Liu, XW; Mu, Y; Pervushin, K; Tang, K; Wei, L; Xu, W; Yan, L; Zhang, H	1
Carey, AL; Durand, C; El-Osta, A; Febbraio, MA; Fröjdö, S; Kingwell, BA; Molin, L; Pirola, L; Solari, F; Vidal, H	1
Szkudelska, K; Szkudelski, T	1
Imaizumi, N; Kitada, M; Koya, D; Kume, S	1
Brasnyó, P; Cseh, J; Halmai, R; Laczy, B; Markó, L; Mérei, A; Mészáros, LG; Mikolás, E; Mohás, M; Molnár, GA; Sümegi, B; Szijártó, IA; Wittmann, I	1
Fu, YC; Wang, W; Yu, W	1
Alipour, MR; Khalili, M; Sheervalilou, R; Soufi, FG; Vardiani, M	1
Minakawa, M; Miura, Y; Yagasaki, K	1
Choi, MS; Do, GM; Jeon, SM; Jung, UJ; Kwon, EY; McGregor, RA; Park, HJ	1
Hoeks, J; Schrauwen, P	1
Koistinen, HA; Semenova, MM; Skrobuk, P; von Kraemer, S; Zitting, A	1
Bhatt, JK; Nanjan, MJ; Thomas, S	1
Hintze, TH; Huang, A; Kaley, G; Sun, D; Yan, C; Yang, YM	1
Chang, YS; Choi, BS; Chung, S; Hong, YA; Kim, HW; Kim, MY; Kim, YS; Ko, SH; Koh, SH; Lee, JH; Lim, JH; Park, CW; Park, HS; Shin, SJ; Yang, KS; Youn, HH	1
Ahn, YB; Kim, HW; Kim, JW; Ko, SH; Lee, EM; Lee, YE; Li, G; Liu, Z; Park, CW; Song, KH; Yoon, KH	1
McCarty, MF	1
Koo, SH; Montminy, M	1
Elliott, PJ; Jirousek, M	1

Reviews

37 review(s) available for resveratrol and Diabetes Mellitus, Type 2

Article	Year
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus. European journal of medicinal chemistry, 2018, May-10, Volume: 151 Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Structure-Activity Relationship	2018
Is resveratrol a prospective therapeutic strategy in the co-association of glucose metabolism disorders and neurodegenerative diseases? Nutritional neuroscience, 2022, Volume: 25, Issue:11 Topics: Alzheimer Disease; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Humans; Neurodegenerative Diseases; Resveratrol	2022
The effects of resveratrol on glycemic control and cardiometabolic parameters in patients with T2DM: A systematic review and meta-analysis. Medicina clinica, 2022, 06-24, Volume: 158, Issue:12 Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Glycemic Control; Humans; Insulin Resistance; Resveratrol	2022
Effect of Resveratrol in Melinjo Seed ( Current diabetes reviews, 2023, Volume: 19, Issue:2 Topics: Diabetes Mellitus, Type 2; Gnetum; Humans; Plant Extracts; Resveratrol; Seeds	2023
Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors. International journal of molecular sciences, 2022, Feb-23, Volume: 23, Issue:5 Topics: Animals; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Induction; Glutathione; Glycosylation; Hesperidin; Humans; Insulin Resistance; Lactoylglutathione Lyase; Mice; Molecular Structure; Neoplasms, Experimental; Obesity; Pyruvaldehyde; Resveratrol	2022
Implications of Resveratrol in Obesity and Insulin Resistance: A State-of-the-Art Review. Nutrients, 2022, Jul-13, Volume: 14, Issue:14 Topics: Animals; Diabetes Mellitus, Type 2; Humans; Insulin; Insulin Resistance; Obesity; PPAR gamma; Resveratrol	2022
Influence of Age and Dose on the Effect of Resveratrol for Glycemic Control in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis. Molecules (Basel, Switzerland), 2022, Aug-16, Volume: 27, Issue:16 Topics: Age Distribution; Blood Glucose; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Glycemic Control; Humans; Insulin; Insulin Resistance; Insulins; Resveratrol	2022
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease. Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12 Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult	2022
Beneficial Effects of ε-Viniferin on Obesity and Related Health Alterations. Nutrients, 2023, Feb-12, Volume: 15, Issue:4 Topics: Animals; Diabetes Mellitus, Type 2; Female; Humans; Male; Mice; Obesity; Resveratrol; Stilbenes; Vitis	2023
Resveratrol for adults with type 2 diabetes mellitus. The Cochrane database of systematic reviews, 2020, Jan-17, Volume: 1 Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Randomized Controlled Trials as Topic; Resveratrol; Treatment Outcome	2020
The effect of resveratrol supplementation on C-reactive protein (CRP) in type 2 diabetic patients: Results from a systematic review and meta-analysis of randomized controlled trials. Complementary therapies in medicine, 2020, Volume: 49 Topics: Anti-Inflammatory Agents; C-Reactive Protein; Diabetes Mellitus, Type 2; Humans; Randomized Controlled Trials as Topic; Resveratrol	2020
A Meta-Analysis of the Impact of Resveratrol Supplementation on Markers of Renal Function and Blood Pressure in Type 2 Diabetic Patients on Hypoglycemic Therapy. Molecules (Basel, Switzerland), 2020, Nov-30, Volume: 25, Issue:23 Topics: Antioxidants; Biomarkers; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dietary Supplements; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Kidney Diseases; Kidney Function Tests; Resveratrol	2020
Resveratrol supplementation and type 2 diabetes: a systematic review and meta-analysis. Critical reviews in food science and nutrition, 2022, Volume: 62, Issue:16 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dietary Supplements; Glycated Hemoglobin; Humans; Insulin Resistance; Resveratrol	2022
The effect of dietary phytochemicals on nuclear factor erythroid 2-related factor 2 (Nrf2) activation: a systematic review of human intervention trials. Molecular biology reports, 2021, Volume: 48, Issue:2 Topics: Adult; Aged; Antioxidants; Bias; Curcumin; Diabetes Mellitus, Type 2; Humans; Isothiocyanates; Middle Aged; NF-E2-Related Factor 2; Obesity; Oxidative Stress; Phytochemicals; Polyphenols; Resveratrol; Sulfoxides	2021
The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials. The American journal of clinical nutrition, 2021, 11-08, Volume: 114, Issue:5 Topics: Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Insulin Resistance; Lipids; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Randomized Controlled Trials as Topic; Resveratrol	2021
Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action. Critical reviews in clinical laboratory sciences, 2017, Volume: 54, Issue:4 Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Mice; Resveratrol; Signal Transduction; Stilbenes	2017
Resveratrol Counteracts Insulin Resistance-Potential Role of the Circulation. Nutrients, 2018, Aug-24, Volume: 10, Issue:9 Topics: Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Muscle, Skeletal; Regional Blood Flow; Resveratrol; Vasodilation; Vasodilator Agents	2018
The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials. Critical reviews in food science and nutrition, 2020, Volume: 60, Issue:3 Topics: Adiponectin; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Leptin; Obesity; Randomized Controlled Trials as Topic; Resveratrol; Weight Loss	2020
Health Effects of Resveratrol: Results from Human Intervention Trials. Nutrients, 2018, Dec-03, Volume: 10, Issue:12 Topics: Biological Availability; Cardiovascular Diseases; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Humans; Resveratrol	2018
Effect of Resveratrol on Blood Lipid Levels in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Obesity (Silver Spring, Md.), 2019, Volume: 27, Issue:1 Topics: Diabetes Mellitus, Type 2; Humans; Hypolipidemic Agents; Lipids; Resveratrol	2019
Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits? Annals of the New York Academy of Sciences, 2013, Volume: 1290 Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Energy Metabolism; Humans; Insurance Benefits; Obesity; Resveratrol; Stilbenes	2013
Can resveratrol help to maintain metabolic health? The Proceedings of the Nutrition Society, 2014, Volume: 73, Issue:2 Topics: Adipose Tissue; Diabetes Mellitus, Type 2; Energy Metabolism; Enzyme Activators; Exercise; Humans; Mitochondria; Muscle, Skeletal; Resveratrol; Sirtuin 1; Stilbenes	2014
New and emerging regulators of intestinal lipoprotein secretion. Atherosclerosis, 2014, Volume: 233, Issue:2 Topics: Animals; Apolipoprotein B-100; Apolipoprotein B-48; Atherosclerosis; Bile Acids and Salts; Cholesterol; Chylomicrons; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fats; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Dyslipidemias; Exenatide; Fatty Acids, Nonesterified; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptide-1 Receptor; Humans; Incretins; Insulin; Insulin Resistance; Intestine, Small; Lipoproteins; Microbiota; Peptides; Receptors, Glucagon; Resveratrol; Secretory Rate; Stilbenes; Triglycerides; Venoms	2014
Modulation of adiponectin as a potential therapeutic strategy. Atherosclerosis, 2014, Volume: 233, Issue:2 Topics: Adiponectin; Antihypertensive Agents; Atherosclerosis; Bariatric Surgery; Cardiovascular Diseases; Clinical Trials as Topic; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Reducing; Exercise; Humans; Hypoglycemic Agents; Insulin Resistance; Life Style; Metabolic Syndrome; Metabolism, Inborn Errors; Obesity; Peroxisome Proliferator-Activated Receptors; Receptors, Adiponectin; Resveratrol; Stilbenes	2014
Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials. The American journal of clinical nutrition, 2014, Volume: 99, Issue:6 Topics: Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes	2014
Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus--systematic review and meta-analysis. Molecular nutrition & food research, 2015, Volume: 59, Issue:1 Topics: Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Databases, Factual; Diabetes Mellitus, Type 2; Dietary Supplements; Glycated Hemoglobin; Humans; Insulin; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes; Triglycerides	2015
Metabolic effects of resveratrol: addressing the controversies. Cellular and molecular life sciences : CMLS, 2015, Volume: 72, Issue:8 Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Cyclic Nucleotide Phosphodiesterases, Type 4; Diabetes Mellitus, Type 2; Humans; Longevity; Neuroprotective Agents; Obesity; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes	2015
[The use of various diet supplements in metabolic syndrome]. Postepy higieny i medycyny doswiadczalnej (Online), 2015, Jan-09, Volume: 69 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Calcium; Caloric Restriction; Diabetes Mellitus, Type 2; Dietary Supplements; Fatty Acids, Omega-3; Garlic; Humans; Magnesium; Metabolic Syndrome; Obesity; Panax; Photinia; Phytotherapy; Plant Preparations; Resveratrol; Risk Reduction Behavior; Selenium; Stilbenes; Tea; Zinc	2015
Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives. Journal of diabetes research, 2016, Volume: 2016 Topics: Catechin; Curcumin; Diabetes Mellitus, Type 2; Humans; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Resveratrol; Stilbenes	2016
Beneficial action of resveratrol: How and why? Nutrition (Burbank, Los Angeles County, Calif.), 2016, Volume: 32, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Autistic Disorder; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Proliferation; Cytochrome P-450 CYP1A1; Diabetes Mellitus, Type 2; Gastrointestinal Microbiome; Gastrointestinal Tract; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-17; Lipoxins; Metabolic Syndrome; NF-kappa B; Resveratrol; Stilbenes; Transcription Factors; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2016
Implications of Resveratrol on Glucose Uptake and Metabolism. Molecules (Basel, Switzerland), 2017, Mar-07, Volume: 22, Issue:3 Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Transport; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Drug Synergism; Glucose; Homeostasis; Humans; Neoplasms; Polyphenols; Resveratrol; Signal Transduction; Stilbenes	2017
Moderate wine consumption in the prevention of metabolic syndrome and its related medical complications. Endocrine, metabolic & immune disorders drug targets, 2008, Volume: 8, Issue:2 Topics: Alcohol Drinking; Animals; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Metabolic Syndrome; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes; Wine	2008
Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutrition reviews, 2008, Volume: 66, Issue:10 Topics: Aging; Animals; Biological Availability; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Enzyme Activation; Enzyme Activators; Humans; Inflammation; Neurodegenerative Diseases; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes	2008
Metabolic benefits from Sirt1 and Sirt1 activators. Current opinion in clinical nutrition and metabolic care, 2009, Volume: 12, Issue:4 Topics: AMP-Activated Protein Kinases; Animals; Caloric Restriction; Diabetes Mellitus, Type 2; Diet; Disease Models, Animal; Energy Metabolism; Humans; Mice; Mice, Transgenic; NAD; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes; Trans-Activators; Transcription, Genetic	2009
Anti-diabetic effects of resveratrol. Annals of the New York Academy of Sciences, 2011, Volume: 1215 Topics: Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Resveratrol; Stilbenes	2011
Cellular and molecular effects of resveratrol in health and disease. Journal of cellular biochemistry, 2012, Volume: 113, Issue:3 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Neurodegenerative Diseases; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes	2012
Sirtuins: novel targets for metabolic disease. Current opinion in investigational drugs (London, England : 2000), 2008, Volume: 9, Issue:4 Topics: Base Sequence; Diabetes Mellitus, Type 2; Energy Metabolism; Enzyme Activators; Enzyme Inhibitors; Humans; Metabolic Diseases; Molecular Sequence Data; Molecular Structure; Obesity; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes	2008

Trials

24 trial(s) available for resveratrol and Diabetes Mellitus, Type 2

Article	Year
Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial. Complementary therapies in medicine, 2022, Volume: 66 Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Glucose; Hemostasis; Humans; Inflammation; Insulin Resistance; MicroRNAs; Oxidative Stress; Resveratrol	2022
Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial. BMC cardiovascular disorders, 2022, 05-10, Volume: 22, Issue:1 Topics: Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Humans; Iran; Non-alcoholic Fatty Liver Disease; Overweight; Resveratrol	2022
Effects of resveratrol therapy on glucose metabolism, insulin resistance, inflammation, and renal function in the elderly patients with type 2 diabetes mellitus: A randomized controlled clinical trial protocol. Medicine, 2022, Aug-12, Volume: 101, Issue:32 Topics: Aged; Blood Glucose; Cytokines; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Inflammation; Insulin; Insulin Resistance; Kidney; Lipids; Randomized Controlled Trials as Topic; Resveratrol; Single-Blind Method	2022
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease. Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12 Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult	2022
The Effect of Resveratrol Supplementation on Cardio-Metabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized, Double-Blind Controlled Trial. Phytotherapy research : PTR, 2019, Volume: 33, Issue:12 Topics: Adult; Blood Glucose; Body Composition; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Male; Middle Aged; Resveratrol; Risk Factors	2019
The effect of resveratrol supplementation on serum levels of asymmetric de-methyl-arginine and paraoxonase 1 activity in patients with type 2 diabetes: A randomized, double-blind controlled trial. Phytotherapy research : PTR, 2020, Volume: 34, Issue:8 Topics: Adult; Arginine; Aryldialkylphosphatase; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Female; Humans; Male; Middle Aged; Resveratrol	2020
The effects of resveratrol supplementation on PPARα, p16, p53, p21 gene expressions, and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: A double-blind controlled randomized trial. Phytotherapy research : PTR, 2021, Volume: 35, Issue:6 Topics: Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cytokine TWEAK; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Female; Gene Expression; Humans; Male; Middle Aged; PPAR alpha; Receptors, Cell Surface; Resveratrol; Tumor Suppressor Protein p53	2021
Resveratrol Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Patients With Type 2 Diabetes Mellitus. International heart journal, 2017, Aug-03, Volume: 58, Issue:4 Topics: Administration, Oral; Ankle Brachial Index; Antioxidants; Atherosclerosis; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oxidative Stress; Resveratrol; Retrospective Studies; Stilbenes; Treatment Outcome; Vascular Stiffness	2017
Impact of sirtuin-1 expression on H3K56 acetylation and oxidative stress: a double-blind randomized controlled trial with resveratrol supplementation. Acta diabetologica, 2018, Volume: 55, Issue:4 Topics: Acetylation; Adult; Aged; Antioxidants; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Down-Regulation; Female; Histones; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Oxidative Stress; Resveratrol; Sirtuin 1; Stilbenes	2018
The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. Acta diabetologica, 2018, Volume: 55, Issue:4 Topics: Adult; Aged; Antioxidants; Biomarkers; Body Weight; C-Reactive Protein; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Female; Humans; Hydrogen Peroxide; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Placebos; Protein Carbonylation; Resveratrol; Stilbenes	2018
Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes. Molecular metabolism, 2018, Volume: 12 Topics: Adipose Tissue, Brown; Aged; Diabetes Mellitus, Type 2; Fatty Acids; Glucose; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Mitochondria, Muscle; Pedigree; Resveratrol	2018
Resveratrol supplementation decreases blood glucose without changing the circulating CD14 Nutrition research (New York, N.Y.), 2018, Volume: 54 Topics: Aged; Antioxidants; Biomarkers; Blood Glucose; Chemokine CCL2; Cytokines; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Female; Humans; Inflammation; Inflammation Mediators; Interleukins; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; NF-kappa B; Plant Extracts; Receptors, IgG; Resveratrol; Toll-Like Receptors; Tumor Necrosis Factor-alpha	2018
Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial. Nutrition & diabetes, 2018, 09-20, Volume: 8, Issue:1 Topics: Absorptiometry, Photon; Aged; Alkaline Phosphatase; Biomarkers; Bone Density; Calcium; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Male; Middle Aged; Phosphorus; Resveratrol; Vitamin D	2018
The effect of resveratrol supplementation on the expression levels of factors associated with cellular senescence and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomised clinical trial. BMJ open, 2019, 07-04, Volume: 9, Issue:7 Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antioxidants; Biomarkers; Cellular Senescence; Cytokine TWEAK; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Randomized Controlled Trials as Topic; Receptors, Cell Surface; Resveratrol	2019
One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacological research, 2013, Volume: 72 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Coronary Artery Disease; Cytokines; Diabetes Mellitus, Type 2; Dietary Supplements; Gene Expression Regulation; Humans; Hypertension; Inflammation; Leukocytes, Mononuclear; Male; MicroRNAs; Middle Aged; Models, Molecular; Plant Extracts; Resveratrol; Stilbenes; Transcriptome; Vitis	2013
Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure. International journal of sport nutrition and exercise metabolism, 2014, Volume: 24, Issue:1 Topics: AMP-Activated Protein Kinases; Basal Metabolism; Diabetes Mellitus, Type 2; Double-Blind Method; Energy Metabolism; Exercise; Glucose Transporter Type 4; Humans; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Physical Exertion; Plant Extracts; Rest; Resveratrol; Sirtuin 1; Stilbenes; Transcription Factors; Vitis	2014
Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial. The American journal of clinical nutrition, 2016, Volume: 103, Issue:1 Topics: Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Energy Intake; Female; Gastric Emptying; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Postprandial Period; Resveratrol; Stilbenes	2016
Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2016, Volume: 26, Issue:5 Topics: Aged; Blood Flow Velocity; Cerebrovascular Circulation; Cerebrovascular Disorders; Cognition; Cognition Disorders; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Middle Cerebral Artery; Posterior Cerebral Artery; Resveratrol; Stilbenes; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasodilation; Victoria	2016
Acute Resveratrol Consumption Improves Neurovascular Coupling Capacity in Adults with Type 2 Diabetes Mellitus. Nutrients, 2016, Jul-12, Volume: 8, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Attention; Blood Flow Velocity; Cerebral Arteries; Cerebrovascular Circulation; Cognition; Cognition Disorders; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Male; Middle Aged; Neurovascular Coupling; New South Wales; Resveratrol; Stilbenes; Time Factors; Trail Making Test; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasodilation	2016
Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial. Pharmacological research, 2016, Volume: 111 Topics: Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Health Status; Humans; Inflammation Mediators; Italy; Resveratrol; Stilbenes; Time Factors; Treatment Outcome	2016
Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. Diabetes care, 2016, Volume: 39, Issue:12 Topics: Adult; Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metformin; Middle Aged; Resveratrol; Stilbenes	2016
Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial. Acta diabetologica, 2017, Volume: 54, Issue:5 Topics: Adult; Aged; Antioxidants; C-Reactive Protein; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Resveratrol; Serum Amyloid P-Component; Stilbenes; Treatment Outcome	2017
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. The British journal of nutrition, 2011, Volume: 106, Issue:3 Topics: Adult; Blood Platelets; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Insulin Resistance; Male; Middle Aged; Oxidative Stress; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Tyrosine	2011
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutrition research (New York, N.Y.), 2012, Volume: 32, Issue:7 Topics: Administration, Oral; Aged; Blood Glucose; Body Mass Index; Cholesterol, LDL; Creatinine; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; India; Male; Middle Aged; Nitrogen; Prospective Studies; Resveratrol; Risk Factors; Stilbenes	2012

Other Studies

81 other study(ies) available for resveratrol and Diabetes Mellitus, Type 2

Article	Year
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature, 2007, Nov-29, Volume: 450, Issue:7170 Topics: Acetylation; Allosteric Site; Animals; Blood Glucose; Caloric Restriction; Catalytic Domain; Cell Line; Diabetes Mellitus, Type 2; Dietary Fats; Disease Models, Animal; Drosophila melanogaster; Heterocyclic Compounds, 4 or More Rings; Humans; Insulin; Male; Mice; Mitochondria; Rats; Rats, Sprague-Dawley; Rats, Zucker; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes	2007
Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators. Journal of medicinal chemistry, 2009, Mar-12, Volume: 52, Issue:5 Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Enzyme Activators; Hypoglycemic Agents; Imidazoles; Mice; Quinoxalines; Rats; Rats, Zucker; Sirtuin 1; Structure-Activity Relationship; Thiazoles	2009
Developing potential agents against atherosclerosis: Design, synthesis and pharmacological evaluation of novel dual inhibitors of oxidative stress and Squalene Synthase activity. European journal of medicinal chemistry, 2017, Sep-29, Volume: 138 Topics: Animals; Atherosclerosis; Cyclooxygenase 1; Cyclooxygenase 2; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Humans; Hypolipidemic Agents; Male; Mice; Mice, Hairless; Molecular Structure; Morpholines; Oxidative Stress; Rats; Structure-Activity Relationship; Thiazines	2017
Knowledge-Based Discovery of the Role and Mechanism of Resveratrol in Improving Glomerular Tether Cell Proliferation and Apoptosis in Diabetic Nephropathy. Journal of healthcare engineering, 2022, Volume: 2022 Topics: Animals; Apoptosis; Cell Proliferation; Cross-Sectional Studies; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Knowledge Discovery; Resveratrol; Streptozocin	2022
Resveratrol Inhibits Metabolism and Affects Blood Platelet Function in Type 2 Diabetes. Nutrients, 2022, Apr-14, Volume: 14, Issue:8 Topics: Blood Platelets; Cardiovascular Diseases; Collagen; Diabetes Mellitus, Type 2; Humans; Platelet Aggregation; Resveratrol; Thrombosis; Thromboxane A2	2022
Resveratrol attenuates behavioural impairment associated with learning and memory in rats with diabetes induced by a high-fat diet and streptozotocin. British journal of pharmacology, 2022, Volume: 179, Issue:19 Topics: Animals; Cholinergic Agents; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose; Oxidative Stress; Rats; Resveratrol; Sirtuin 1; Streptozocin; Transforming Growth Factor beta1	2022
Potential mechanisms underlying the association between type II diabetes mellitus and cognitive dysfunction in rats: a link between miRNA-21 and Resveratrol's neuroprotective action. Metabolic brain disease, 2022, Volume: 37, Issue:7 Topics: Animals; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Insulin; Lipids; MicroRNAs; Rats; Resveratrol; Streptozocin	2022
Combined resveratrol and vitamin D treatment ameliorate inflammation-related liver fibrosis, ER stress, and apoptosis in a high-fructose diet/streptozotocin-induced T2DM model. Histochemistry and cell biology, 2022, Volume: 158, Issue:3 Topics: Animals; Antioxidants; Apoptosis; Caspase 3; Diabetes Mellitus, Type 2; Diet; Endoplasmic Reticulum Stress; Fructose; Inflammation; Interleukin-6; Liver Cirrhosis; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Streptozocin; Tumor Necrosis Factor-alpha; Vitamin D	2022
Resveratrol improves diabetic cardiomyopathy by preventing asymmetric dimethylarginine-caused peroxisome proliferator-activated receptor-γ coactivator-1α acetylation. European journal of pharmacology, 2022, Dec-05, Volume: 936 Topics: Acetylation; Animals; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Myocytes, Cardiac; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Rats; Resveratrol; Sirtuin 1	2022
Effects of SIRT1 on Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in Type 2 Diabetic Patients. Endocrine, metabolic & immune disorders drug targets, 2023, Volume: 23, Issue:8 Topics: Cell Differentiation; Cells, Cultured; Diabetes Mellitus, Type 2; Humans; Mesenchymal Stem Cells; Osteogenesis; Osteoporosis; Resveratrol; Sirtuin 1	2023
Metformin enhances anti-cancer properties of resveratrol in MCF-7 breast cancer cells via induction of apoptosis, autophagy and alteration in cell cycle distribution. Biochemical and biophysical research communications, 2023, 02-12, Volume: 644 Topics: Autophagy; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Diabetes Mellitus, Type 2; Female; G1 Phase Cell Cycle Checkpoints; Humans; Male; MCF-7 Cells; Metformin; Resveratrol	2023
Dysregulation of Gene Expression of Key Signaling Mediators in PBMCs from People with Type 2 Diabetes Mellitus. International journal of molecular sciences, 2023, Feb-01, Volume: 24, Issue:3 Topics: Diabetes Mellitus, Type 2; Gene Expression; Humans; Inflammation; Leukocytes, Mononuclear; Lipopolysaccharides; Proteasome Endopeptidase Complex; Resveratrol; Signal Transduction	2023
Resveratrol ameliorates ortho- polychlorinated biphenyls' induced toxicity in ovary cells. Environmental science and pollution research international, 2023, Volume: 30, Issue:31 Topics: Diabetes Mellitus, Type 2; Female; Humans; Ovary; Polychlorinated Biphenyls; Resveratrol	2023
Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to Neuroinflammation. International journal of molecular sciences, 2023, Jul-19, Volume: 24, Issue:14 Topics: Astrocytes; Diabetes Mellitus, Type 2; Endothelial Cells; Humans; Lipopolysaccharides; Neuroinflammatory Diseases; Resveratrol; Sirtuin 1	2023
The Role of Glucose Concentration and Resveratrol in Modulating Neuroinflammatory Cytokines: Insights from an In Vitro Blood-Brain Barrier Model. Medical science monitor : international medical journal of experimental and clinical research, 2023, Oct-11, Volume: 29 Topics: Blood-Brain Barrier; Cytokines; Diabetes Mellitus, Type 2; Endothelial Cells; Glucose; Humans; Hyperglycemia; Neuroinflammatory Diseases; Resveratrol; Tumor Necrosis Factor-alpha	2023
Effects of Resveratrol in Goto-Kakizaki Rat, a Model of Type 2 Diabetes. Nutrients, 2019, Oct-16, Volume: 11, Issue:10 Topics: Acetyl-CoA Carboxylase; Adipokines; AMP-Activated Protein Kinases; Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Hypoglycemic Agents; Islets of Langerhans; Lipids; Liver; Male; Muscle, Skeletal; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Resveratrol	2019
A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling. Acta pharmacologica Sinica, 2020, Volume: 41, Issue:3 Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Kelch-Like ECH-Associated Protein 1; Ketones; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Morpholines; NF-E2-Related Factor 2; Oxidative Stress; Resveratrol; Signal Transduction; Structure-Activity Relationship	2020
Effect of resveratrol on dipeptidyl peptidase-4 inhibitors pharmacokinetics: An in vitro and in vivo approach. Chemico-biological interactions, 2020, Jan-05, Volume: 315 Topics: Animals; Antioxidants; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol	2020
Resveratrol increase myocardial Nrf2 expression in type 2 diabetic rats and alleviate myocardial ischemia/reperfusion injury (MIRI). Annals of palliative medicine, 2019, Volume: 8, Issue:5 Topics: Animals; Antioxidants; Diabetes Mellitus, Type 2; Disease Models, Animal; Heart; Myocardial Reperfusion Injury; Myocardium; NF-E2-Related Factor 2; Rats; Resveratrol; Up-Regulation	2019
Resveratrol inhibits adipocyte differentiation and cellular senescence of human bone marrow stromal stem cells. Bone, 2020, Volume: 133 Topics: Adipocytes; Adipogenesis; Aged; Bone Marrow Cells; Cell Differentiation; Cellular Senescence; Diabetes Mellitus, Type 2; Humans; Mesenchymal Stem Cells; Osteoblasts; Osteogenesis; Resveratrol	2020
Resveratrol ameliorates inflammatory and oxidative stress in type 2 diabetic Goto-Kakizaki rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 125 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Inflammation Mediators; Lipid Peroxidation; Liver; Oxidative Stress; Rats; Resveratrol	2020
Resveratrol treatment promotes titanium implant osseointegration in diabetes mellitus rats. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2020, Volume: 38, Issue:10 Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Male; Osseointegration; Rats, Sprague-Dawley; Resveratrol; X-Ray Microtomography	2020
NLRP3 inflammasome drives inflammation in high fructose fed diabetic rat liver: Effect of resveratrol and metformin. Life sciences, 2020, Jul-15, Volume: 253 Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fructose; Hypoglycemic Agents; Inflammasomes; Inflammation; Insulin Resistance; Liver; Male; Metformin; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Resveratrol	2020
Long non-coding RNA expression profiling following treatment with resveratrol to improve insulin resistance. Molecular medicine reports, 2020, Volume: 22, Issue:2 Topics: Animals; Cell Line, Tumor; Diabetes Mellitus, Type 2; Gene Expression; Glucose-6-Phosphatase; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Resveratrol; RNA, Long Noncoding; Suppressor of Cytokine Signaling 3 Protein	2020
Resveratrol reduces excessive cholesterol accumulation in Goto-Kakizaki rat, a model with congenital type 2 diabetes. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2020, Volume: 71, Issue:4 Topics: Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Disease Models, Animal; Hormones; Male; Rats, Sprague-Dawley; Resveratrol; Tissue Distribution	2020
Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis Food & function, 2021, Feb-15, Volume: 12, Issue:3 Topics: Animals; Antioxidants; Benzhydryl Compounds; Cell Line; Diabetes Mellitus, Type 2; Diet, High-Fat; Forkhead Box Protein O1; Gene Expression Regulation; Gluconeogenesis; Glucose; Glucosides; Humans; Male; Mice; Mice, Obese; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Resveratrol; Sodium-Glucose Transporter 2 Inhibitors; Up-Regulation	2021
Resveratrol-induced remodelling of myocellular lipid stores: A study in metabolically compromised humans. Physiological reports, 2021, Volume: 9, Issue:2 Topics: Antioxidants; Athletes; Biopsy; Diabetes Mellitus, Type 2; Exercise; Humans; Insulin Resistance; Lipid Droplets; Lipid Metabolism; Middle Aged; Muscle Fibers, Skeletal; Muscle, Skeletal; Primary Cell Culture; Quadriceps Muscle; Randomized Controlled Trials as Topic; Resveratrol	2021
Resveratrol ameliorates type 2 diabetes mellitus-induced alterations to the knee joint articular cartilage ultrastructure in rats. Ultrastructural pathology, 2021, Mar-04, Volume: 45, Issue:2 Topics: Animals; Cartilage, Articular; Chondrocytes; Diabetes Mellitus, Type 2; Knee Joint; Osteoarthritis; Rats; Resveratrol	2021
Resveratrol Affects Insulin Signaling in Type 2 Diabetic Goto-Kakizaki Rats. International journal of molecular sciences, 2021, Feb-28, Volume: 22, Issue:5 Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Insulin; Male; Phosphorylation; Rats; Receptor, Insulin; Resveratrol; Signal Transduction	2021
Trans-resveratrol imparts disparate effects on transcription of DNA damage sensing/repair pathway genes in euglycemic and hyperglycemic rat testis. Toxicology and applied pharmacology, 2021, 05-01, Volume: 418 Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Blood Glucose; Cell Cycle Checkpoints; Cell Cycle Proteins; Diabetes Mellitus, Type 2; Disease Models, Animal; DNA Damage; DNA Repair; Gene Expression Regulation; Male; Rats, Wistar; Resveratrol; Testis; Transcription, Genetic	2021
Influence of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase II metabolites in the Zucker diabetic fatty rat. Molecular nutrition & food research, 2017, Volume: 61, Issue:10 Topics: Animals; Anthocyanins; Biological Availability; Blood Glucose; Brain; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavonoids; Grape Seed Extract; Male; Polyphenols; Quercetin; Rats; Rats, Zucker; Resveratrol; Stilbenes; Tandem Mass Spectrometry; Vitis	2017
Comment on Timmers et al. Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2016;39:2211-2217. Diabetes care, 2017, Volume: 40, Issue:9 Topics: Diabetes Mellitus, Type 2; Humans; Resveratrol; Stilbenes; Vitamin D	2017
Response to Comment on Timmers et al. Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2016;39:2211-2217. Diabetes care, 2017, Volume: 40, Issue:9 Topics: Diabetes Mellitus, Type 2; Humans; Resveratrol; Stilbenes; Vitamin D	2017
Resveratrol Increases Hepatic SHBG Expression through Human Constitutive Androstane Receptor: a new Contribution to the French Paradox. Scientific reports, 2017, 09-25, Volume: 7, Issue:1 Topics: Alcohol Drinking; Animals; Biopsy; Cardiovascular Diseases; Constitutive Androstane Receptor; Culture Media; Diabetes Mellitus, Type 2; Female; Genes, Reporter; Hep G2 Cells; Humans; Liver; Luciferases; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Transgenic; Receptors, Cytoplasmic and Nuclear; Resveratrol; Sex Hormone-Binding Globulin; Wine	2017
Resveratrol regulates hyperglycemia-induced modulations in experimental diabetic animal model. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 102 Topics: Animals; Antioxidants; Blood Glucose; Calcium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Hyperglycemia; Insulin; Insulin Resistance; Magnesium; Male; Metformin; Rats; Resveratrol; Stilbenes; Vitamin E	2018
Effect of resveratrol in type 2 diabetes oxidative stress markers: a reassessment. Acta diabetologica, 2018, Volume: 55, Issue:7 Topics: Antioxidants; Biomarkers; Diabetes Mellitus, Type 2; Humans; Oxidative Stress; Resveratrol; Stilbenes	2018
Reply to Letter to the Editor "The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial". Acta diabetologica, 2018, Volume: 55, Issue:7 Topics: Biomarkers; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Humans; Oxidative Stress; Resveratrol; Stilbenes	2018
Resveratrol attenuates hIAPP amyloid formation and restores the insulin secretion ability in hIAPP-INS1 cell line via enhancing autophagy. Canadian journal of physiology and pharmacology, 2019, Volume: 97, Issue:2 Topics: Animals; Autophagy; Cell Line, Tumor; Diabetes Mellitus, Type 2; Insulin Secretion; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Rats; Resveratrol	2019
Resveratrol Mitigates High-Fat Diet-Induced Vascular Dysfunction by Activating the Akt/eNOS/NO and Sirt1/ER Pathway. Journal of cardiovascular pharmacology, 2018, Volume: 72, Issue:5 Topics: Abdominal Muscles; Animals; Aorta, Thoracic; Blood Vessels; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diet, High-Fat; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred C57BL; Microvessels; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Resveratrol; Signal Transduction; Sirtuin 1	2018
Diabetes induces tri-methylation at lysine 9 of histone 3 at Slc2a4 gene in skeletal muscle: A new target to improve glycemic control. Molecular and cellular endocrinology, 2019, 02-05, Volume: 481 Topics: Animals; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Models, Animal; Epigenesis, Genetic; Glucose Transporter Type 4; Histones; Humans; Insulin; Lysine; Male; Methylation; Mice; Muscle, Skeletal; Promoter Regions, Genetic; Rats; Resveratrol	2019
Protective Effect of Resveratrol against Ischemia-Reperfusion Injury via Enhanced High Energy Compounds and eNOS-SIRT1 Expression in Type 2 Diabetic Female Rat Heart. Nutrients, 2019, Jan-06, Volume: 11, Issue:1 Topics: Adenosine Triphosphate; Animals; Cardiotonic Agents; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Energy Metabolism; Female; Gene Expression; Magnetic Resonance Spectroscopy; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphocreatine; Rats; Rats, Wistar; Resveratrol; Sirtuin 1	2019
Ameliorating Methylglyoxal-Induced Progenitor Cell Dysfunction for Tissue Repair in Diabetes. Diabetes, 2019, Volume: 68, Issue:6 Topics: Animals; Bone Marrow Cells; Cell- and Tissue-Based Therapy; Diabetes Mellitus, Type 2; Disease Models, Animal; Endoribonucleases; Gene Knock-In Techniques; Gene Transfer Techniques; Hesperidin; Lactoylglutathione Lyase; Mice; Neovascularization, Physiologic; Protein Serine-Threonine Kinases; Pyruvaldehyde; Resveratrol; Skin; Stem Cells; Wound Healing; Wounds and Injuries	2019
Rs12778366 single nucleotide polymorphism of Sirtuin 1 (SIRT1) and response to resveratrol supplementation in patients with type 2 diabetes mellitus. Acta diabetologica, 2019, Volume: 56, Issue:8 Topics: Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Resveratrol; Sirtuin 1	2019
Resveratrol supplementation improves DNA integrity and sperm parameters in streptozotocin-nicotinamide-induced type 2 diabetic rats. Andrologia, 2019, Volume: 51, Issue:8 Topics: Animals; Antioxidants; Chromatin; Chromatin Assembly and Disassembly; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; DNA; DNA Fragmentation; Dose-Response Relationship, Drug; Humans; Infertility, Male; Male; Niacinamide; Rats; Rats, Wistar; Resveratrol; Sperm Count; Sperm Motility; Spermatozoa; Streptozocin; Treatment Outcome	2019
In vitro effects of resveratrol on oxidative stress in diabetic platelets. Acta diabetologica, 2014, Volume: 51, Issue:1 Topics: Adult; Aged; Antioxidants; Blood Platelets; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Male; Membrane Fluidity; Middle Aged; Oxidative Stress; Resveratrol; Stilbenes	2014
Stilbene analogs of resveratrol improve insulin resistance through activation of AMPK. Bioscience, biotechnology, and biochemistry, 2013, Volume: 77, Issue:6 Topics: 3T3-L1 Cells; Adipocytes; AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose; Humans; Insulin; Insulin Resistance; Mice; Obesity; Resveratrol; Stilbenes	2013
Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet. Diabetes, 2013, Volume: 62, Issue:10 Topics: Animals; Blood Glucose; Body Weight; Cell Dedifferentiation; Densitometry; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Sucrose; Disease Models, Animal; Fluorescent Antibody Technique; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose Tolerance Test; Glycated Hemoglobin; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Macaca mulatta; Nuclear Proteins; Protective Agents; Resveratrol; Sirtuin 1; Stilbenes; Transcription Factors	2013
Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1. Oncology reports, 2013, Volume: 30, Issue:6 Topics: Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Diabetes Mellitus, Type 2; Gene Expression Regulation, Neoplastic; Glucose; Hep G2 Cells; Humans; Liver Neoplasms; Resveratrol; RNA, Small Interfering; Signal Transduction; Sirtuin 1; STAT3 Transcription Factor; Stilbenes	2013
Submaximal ADP-stimulated respiration is impaired in ZDF rats and recovered by resveratrol. The Journal of physiology, 2013, Dec-01, Volume: 591, Issue:23 Topics: Adenine Nucleotide Translocator 2; Adenosine Diphosphate; Animals; Cell Respiration; Diabetes Mellitus, Type 2; Glutathione; Glutathione Disulfide; Hydrogen Peroxide; Insulin Resistance; Male; Mitochondria; Muscle, Skeletal; Rats; Rats, Zucker; Resveratrol; Stilbenes	2013
Protective effects of chronic resveratrol treatment on vascular inflammatory injury in steptozotocin-induced type 2 diabetic rats: role of NF-kappa B signaling. European journal of pharmacology, 2013, Nov-15, Volume: 720, Issue:1-3 Topics: Animals; Aorta, Thoracic; Capillary Permeability; Carotid Arteries; Carotid Artery Injuries; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Endothelial Cells; Humans; Hypoglycemic Agents; Insulin; Interleukin-1beta; Interleukin-6; Lipids; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes	2013
Anti-inflammatory properties of resveratrol in the retinas of type 2 diabetic rats. Clinical and experimental pharmacology & physiology, 2015, Volume: 42, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus, Type 2; Inflammation Mediators; Insulin; Male; Rats; Rats, Wistar; Resveratrol; Retina; Stilbenes	2015
Resveratrol treatment restores peripheral insulin sensitivity in diabetic mice in a sirt1-independent manner. Molecular nutrition & food research, 2015, Volume: 59, Issue:8 Topics: Animals; Antioxidants; Crosses, Genetic; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Enzyme Inhibitors; Female; Hypoglycemic Agents; Insulin Receptor Substrate Proteins; Insulin Resistance; Islets of Langerhans; Liver; Male; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Muscle, Skeletal; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Resveratrol; Sirtuin 1; Stilbenes	2015
The cardioprotective effects of resveratrol in rats with simultaneous type 2 diabetes and renal hypertension. Natural product communications, 2015, Volume: 10, Issue:2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Heart Diseases; Hypertension, Renal; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes	2015
Palmitic acid increases pro-oxidant adaptor protein p66Shc expression and affects vascularization factors in angiogenic mononuclear cells: Action of resveratrol. Vascular pharmacology, 2015, Volume: 75 Topics: Antioxidants; Case-Control Studies; Cell Movement; Cells, Cultured; Diabetes Mellitus, Type 2; Gene Expression Regulation; Gene Silencing; Humans; Leukocytes, Mononuclear; Male; Metabolic Syndrome; Middle Aged; Neovascularization, Physiologic; Oxidative Stress; Palmitic Acid; Resveratrol; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Stilbenes	2015
Effects of Resveratrol on Receptor for Advanced Glycation End Products (RAGE) Expression and Oxidative Stress in the Liver of Rats with Type 2 Diabetes. Phytotherapy research : PTR, 2016, Volume: 30, Issue:1 Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Lipid Peroxidation; Liver; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Resveratrol; Stilbenes	2016
Resveratrol Ameliorates Clonidine-Induced Endothelium-Dependent Relaxation Involving Akt and Endothelial Nitric Oxide Synthase Regulation in Type 2 Diabetic Mice. Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:12 Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Antioxidants; Clonidine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Synergism; Endothelium, Vascular; Male; Mice, Inbred ICR; Nitric Oxide Synthase; Phosphorylation; Plant Extracts; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes; Vasodilation	2015
Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat. Pathology, research and practice, 2016, Volume: 212, Issue:4 Topics: Animals; Antioxidants; Autophagy; Blotting, Western; Cell Hypoxia; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Gene Knockdown Techniques; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Sirtuin 1; Stilbenes	2016
Resveratrol Cardioprotection Against Myocardial Ischemia/Reperfusion Injury Involves Upregulation of Adiponectin Levels and Multimerization in Type 2 Diabetic Mice. Journal of cardiovascular pharmacology, 2016, Volume: 68, Issue:4 Topics: Adiponectin; Animals; Cardiotonic Agents; Diabetes Mellitus, Type 2; Male; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Protein Multimerization; Random Allocation; Resveratrol; Stilbenes; Up-Regulation	2016
Sirtuin 1 and 7 mediate resveratrol-induced recovery from hyper-anxiety in high-fructose-fed prediabetic rats. Journal of biosciences, 2016, Volume: 41, Issue:3 Topics: Animals; Antioxidants; Anxiety Disorders; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet; Epigenesis, Genetic; Fructose; Gene Expression Regulation; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Prediabetic State; Rats; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes	2016
Resveratrol Attenuates Copper and Zinc Homeostasis and Ameliorates Oxidative Stress in Type 2 Diabetic Rats. Biological trace element research, 2017, Volume: 177, Issue:1 Topics: Administration, Oral; Animals; Copper; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Homeostasis; Male; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase; Zinc	2017
Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol. Chembiochem : a European journal of chemical biology, 2009, Feb-13, Volume: 10, Issue:3 Topics: Amyloid; Animals; Antioxidants; Cell Line; Diabetes Mellitus, Type 2; Humans; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Molecular Structure; Protein Conformation; Rats; Resveratrol; Stilbenes; Wine	2009
Fluorescence microscopy studies on islet amyloid polypeptide fibrillation at heterogeneous and cellular membrane interfaces and its inhibition by resveratrol. FEBS letters, 2009, May-06, Volume: 583, Issue:9 Topics: Amyloid; Animals; Cell Line; Cell Membrane; Diabetes Mellitus, Type 2; Humans; Islet Amyloid Polypeptide; Membrane Lipids; Microscopy, Fluorescence; Resveratrol; Stilbenes	2009
Resveratrol induces mitochondrial biogenesis in endothelial cells. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:1 Topics: Animals; Antioxidants; Aorta, Thoracic; Cells, Cultured; Diabetes Mellitus, Type 2; DNA, Mitochondrial; Electron Transport; Endothelial Cells; Endothelium, Vascular; Enzyme Induction; Mice; Mitochondria; Nitric Oxide Synthase Type III; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Sirtuin 1; Sirtuins; Stilbenes	2009
Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress. Arteriosclerosis, thrombosis, and vascular biology, 2009, Volume: 29, Issue:8 Topics: Animals; Aorta; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Tumor Necrosis Factor-alpha; Vasodilation; Vasodilator Agents	2009
Central administration of resveratrol improves diet-induced diabetes. Endocrinology, 2009, Volume: 150, Issue:12 Topics: Animals; Antioxidants; Blotting, Western; Body Weight; Brain; Diabetes Mellitus, Type 2; Dietary Fats; Eating; Glucose; Homeostasis; Hyperglycemia; Liver; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Protein Serine-Threonine Kinases; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Sirtuin 1; Stilbenes	2009
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. The Journal of biological chemistry, 2010, Mar-12, Volume: 285, Issue:11 Topics: Acetylation; Allosteric Regulation; Animals; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dietary Fats; Enzyme Activation; Enzyme Inhibitors; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Mice, Obese; Nuclear Magnetic Resonance, Biomolecular; Resveratrol; Rhodamines; Sirtuin 1; Stilbenes; Substrate Specificity; Surface Plasmon Resonance; Tumor Suppressor Protein p53	2010
Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes. Phytotherapy research : PTR, 2011, Volume: 25, Issue:1 Topics: Adiponectin; Animals; Body Weight; Chemotherapy, Adjuvant; Cholesterol; Diabetes Mellitus, Type 2; Enzyme Activation; Fatty Acids, Nonesterified; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Mice; Resveratrol; Sirtuin 1; Stilbenes; Triglycerides	2011
Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging. American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:4 Topics: Animals; Antioxidants; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; NADPH Oxidase 2; NADPH Oxidases; NF-kappa B; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Oxygen; Reactive Oxygen Species; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left	2010
The molecular basis of distinct aggregation pathways of islet amyloid polypeptide. The Journal of biological chemistry, 2011, Feb-25, Volume: 286, Issue:8 Topics: Amyloid; Diabetes Mellitus, Type 2; Humans; Islet Amyloid Polypeptide; Microscopy, Atomic Force; Nuclear Magnetic Resonance, Biomolecular; Protein Multimerization; Resveratrol; Stilbenes	2011
Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Molecular and cellular endocrinology, 2011, Mar-30, Volume: 335, Issue:2 Topics: Adult; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Case-Control Studies; Cell Line; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Longevity; Middle Aged; Muscle Fibers, Skeletal; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Binding; Recombinant Fusion Proteins; Resveratrol; RNA Interference; Signal Transduction; Sirtuin 1; Stilbenes; Tumor Necrosis Factor-alpha	2011
Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes, 2011, Volume: 60, Issue:2 Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Blotting, Western; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Immunohistochemistry; Immunoprecipitation; Kidney; Male; Mice; Oxidative Stress; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sirtuin 1; Stilbenes; Superoxide Dismutase	2011
Chronic resveratrol administration has beneficial effects in experimental model of type 2 diabetic rats. Endocrine regulations, 2012, Volume: 46, Issue:2 Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Hyperglycemia; Male; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase	2012
Piceatannol, a resveratrol derivative, promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and suppresses blood glucose levels in type 2 diabetic model db/db mice. Biochemical and biophysical research communications, 2012, Jun-08, Volume: 422, Issue:3 Topics: AMP-Activated Protein Kinase Kinases; Animals; Blood Glucose; Cell Line; Cell Membrane; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Activation; Glucose; Glucose Transporter Type 4; Mice; Molecular Imaging; Muscle Cells; Protein Kinases; Rats; Resveratrol; Stilbenes	2012
Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. Molecular nutrition & food research, 2012, Volume: 56, Issue:8 Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dietary Supplements; Dyslipidemias; Glucose Transporter Type 4; Glycated Hemoglobin; Glycogen; Insulin; Insulin Secretion; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Muscle, Skeletal; Resveratrol; Rosiglitazone; Stilbenes; Thiazolidinediones; Triglycerides	2012
Muscle mitochondria and insulin resistance: a human perspective. Trends in endocrinology and metabolism: TEM, 2012, Volume: 23, Issue:9 Topics: Animals; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Mitochondria, Muscle; Resveratrol; Stilbenes	2012
Acute exposure to resveratrol inhibits AMPK activity in human skeletal muscle cells. Diabetologia, 2012, Volume: 55, Issue:11 Topics: AMP-Activated Protein Kinases; Cell Differentiation; Diabetes Mellitus, Type 2; Drug Interactions; Enzyme Inhibitors; Glucose; Glycogen; Humans; Insulin Resistance; Male; Middle Aged; Muscle Fibers, Skeletal; Palmitates; Phosphorylation; Primary Cell Culture; Resveratrol; Signal Transduction; Stilbenes	2012
Altered MAPK signaling in progressive deterioration of endothelial function in diabetic mice. Diabetes, 2012, Volume: 61, Issue:12 Topics: Animals; Anthracenes; Butadienes; Diabetes Mellitus, Type 2; Extracellular Signal-Regulated MAP Kinases; Imidazoles; Immunoblotting; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mitogen-Activated Protein Kinases; Nitriles; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Receptors, Leptin; Resveratrol; Signal Transduction; Stilbenes; Superoxides	2012
Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice. Diabetologia, 2013, Volume: 56, Issue:1 Topics: AMP-Activated Protein Kinases; Animals; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme Activation; Kidney; Lipid Metabolism; Lipotropic Agents; Male; Mesangial Cells; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Oxidative Stress; Protective Agents; Protein Processing, Post-Translational; Resveratrol; RNA Interference; Signal Transduction; Sirtuin 1; Stilbenes; Transcription Factors	2013
Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db/db mice. PloS one, 2012, Volume: 7, Issue:11 Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Blood Glucose; Deoxyguanosine; Diabetes Mellitus, Type 2; Disease Models, Animal; Fibrosis; Glucose Tolerance Test; Immunohistochemistry; Insulin; Insulin Resistance; Islets of Langerhans; Male; Mice; Organ Size; Oxidative Stress; Resveratrol; Stilbenes	2012
Potential utility of natural polyphenols for reversing fat-induced insulin resistance. Medical hypotheses, 2005, Volume: 64, Issue:3 Topics: Adipocytes; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Flavonoids; Humans; I-kappa B Kinase; Insulin Resistance; Models, Biological; Phenols; Polyphenols; Probenecid; Protein Serine-Threonine Kinases; Resveratrol; Silybin; Silymarin; Stilbenes	2005
In vino veritas: a tale of two sirt1s? Cell, 2006, Dec-15, Volume: 127, Issue:6 Topics: Acetylation; Administration, Oral; Aging; Animals; Diabetes Mellitus, Type 2; Energy Metabolism; Glucose; Homeostasis; Humans; Insulin; Longevity; Male; Mice; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Signal Transduction; Sirtuin 1; Sirtuins; Stilbenes; Trans-Activators; Transcription Factors	2006